BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szeliga A, Rudnicka E, Maciejewska-jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R, Meczekalski B. Neuroendocrine Determinants of Polycystic Ovary Syndrome. IJERPH 2022;19:3089. [DOI: 10.3390/ijerph19053089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li W, Liu C, Yang Q, Zhou Y, Liu M, Shan H. Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1018674] [Reference Citation Analysis]
2 Ye Y, Zhou C, Hu H, Fukuzawa I, Zhang H. Underlying mechanisms of acupuncture therapy on polycystic ovary syndrome: Evidences from animal and clinical studies. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1035929] [Reference Citation Analysis]
3 Xing C, Zhao H, Zhang J, He B. Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome. Front Endocrinol 2022;13:945609. [DOI: 10.3389/fendo.2022.945609] [Reference Citation Analysis]
4 Zhao H, Chen R, Zheng D, Xiong F, Jia F, Liu J, Zhang L, Zhang N, Zhu S, Liu Y, Zhao L, Liu X. Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota. Front Cell Infect Microbiol 2022;12:854796. [DOI: 10.3389/fcimb.2022.854796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]